TrialLancet (London, England)2018

Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trials.

Kayvon Modjarrad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.